Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – New research suggests that when noncalcified lung nodules are detected by computed tomography (CT), assessment of their volume and volume-doubling time with repeat…
NEW YORK (Reuters Health) – Intensive statin therapy is more effective than standard doses in reducing the risk of major adverse events after angioplasty for acute coronary syndromes…
NEW YORK (Reuters Health) – A large study of revascularization strategies in diabetics with multivessel coronary artery disease, which set out to show that angioplasty is not inferior…
NEW YORK (Reuters Health) – Continuing to take low-dose aspirin after endoscopic treatment of a bleeding peptic ulcer raises the risk for re-bleeding but may also reduce mortality…
NEW YORK (Reuters Health) – Giving intravenous drugs during out-of-hospital cardiac arrest does not improve survival, according to a study in the Journal of the American Medical Association…
NEW YORK (Reuters Health) – Adding cetuximab to standard chemotherapy for colorectal liver metastases often shrinks inoperable lesions enough to permit resection, according to a study released today…
NEW YORK (Reuters Health) – Systolic blood pressure, left ventricular (LV) mass, and diabetes status independently predict the likelihood that prehypertensive patients with cardiac risk factors will develop…
NEW YORK (Reuters Health) – Transradial percutaneous coronary intervention (PCI) for acute MI is associated with a lower risk of major bleeding and other adverse events than transfemoral…
NEW YORK (Reuters Health) – Treating HER-2 positive, metastatic breast cancer with trastuzumab significantly increased survival in a retrospective study, to the point were such women given the…
NEW YORK (Reuters Health) – In patients receiving glucocorticoids for inflammatory diseases, adverse events are very common, even at low to medium doses, according to a meta-analysis by…
